Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian

Breadcrumb

  1. Home
  2. Microbiota and child health
  3. Nasal microbiota: a reliable marker of bronchiolitis severity
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographic
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Microbiota and child health
  3. Nasal microbiota: a reliable marker of bronchiolitis severity
Pediatrics

Nasal microbiota: a reliable marker of bronchiolitis severity

Bronchiolitis
Pulmonology Pediatrics

The severity of bronchiolitis in newborns may be assessed by characterizing their nasal microbiota. This could be an alternative, simpler and less invasive method than a nasopharyngeal aspirate, which is conventionally used.

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographic
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • Mail

Sections

About this article

Created 21 October 2019
Updated 12 October 2021

.

ASPIRATE VS. SWAB

As is the case for bronchiolitis, characterization of the airway microbiota takes on a particular importance in some pulmonary pathologies. The severity of the disease is direct y correlated with the local microbial populations. Consequently, accurate identification of the microorganisms present proves essential and requires high-quality sampling. Standard protocol (nasopharyngeal aspirate) of fers good diagnostic and prognostic efficacy. But the procedure is invasive and proves tricky to perform in children, in particular in infants. Simpler to perform and less traumatic, nasal swab is a promising alternative. Its efficacy was studied by comparing the nasopharyngeal and nasal microbiota of infants with bronchiolitis (composition / capacity to predict the severity of the inflammatory episode).16 Both sampling techniques were assessed in 815 hospitalized children; bacterial populations were characterized by amplification of 16S rRNA genes.

DIFFERENT POPULATIONS, BUT SIMILAR PREDICTABILITY

The analyses show a disparity between the microbial populations of the two areas. The nasal microbiota is composed mainly of the genera Staphylococcus (40.8%), Corynebacterium (10.4%), Moraxella (9.3%), Haemophilus (7.4%), Dolosigranulum (5.2%), Streptococcus (5%) and Enterobacter (4.7%). However, the nasopharyngeal microbiota is dominated by the genera Moraxella (30.7%), Streptococcus (30.5%) and Haemophilus (19.7%). These differences however should be put in perspective: predominance of Moraxella or Haemophilus in the nasal area is also found in the nasopharynx, making these two sites a good tool for predicting the severity of bronchiolitis. Children with a Haemophilus-dominant profile display an increased risk of requiring intensive care or prolonged hospitalization (≥ 5 days). In comparison, subjects with a Moraxella-dominant profile seem to be the least at risk. This predictive capacity is not however applicable to other bacterial genera. The nasal swab presents many practical advantages, and can therefore be considered a valid alternative to nasopharyngeal aspirate in assessing the severity of bronchiolitis in infants.

Sources

16 Luna PN, Hasegawa K, Ajami NJ, et al. The association between anterior nares and nasopharyngeal microbiota in infants hospitalized for bronchiolitis. Microbiome. 2018;6(1):2.

Old sources

 

 

Tags
Bronchiolitis Children & baby health

en_view en_sources

    Focus
    Microbiota and child health
    • Impact of antibiotics
      • Antibiotics, child microbiota and long-term health effects
      • Focus on the risks of excess weight and obesity
      • Zoom on the risks of IBD
    • Behavioral disorders
      • The role of oral and intestinal microbiota and mycobiome in autism
      • Gut-brain axis and ADHD in adolescents
    • Respiratory diseases
      • Respiratory microbiota and pulmonary infections associated with cystic fibrosis
      • Nasal microbiota: a reliable marker of bronchiolitis severity
    • Gastrointestinal disorders
      • Infectious diarrhea and intestinal microbiota
      • Is intestinal dysbiosis the cause of persistent diarrhea?
    • Expert opinion
      • Pr. Olivier Goulet : Gastrointestinal disorders in children, the need to act
    Created 21 October 2019
    Updated 12 October 2021

    About this article

    To know more about this topic.

    Main topic

    Bronchiolitis

    Medical practice

    Pulmonology Pediatrics

    Content type

    Dossier detail
    Respiratory microbiota and pulmonary infections associated with cystic fibrosis
    Infectious diarrhea and intestinal microbiota
    Focus

    Microbiota and child health

    Impact of antibiotics

    Antibiotics, child microbiota and long-term health effects Focus on the risks of excess weight and obesity Zoom on the risks of IBD

    Behavioral disorders

    The role of oral and intestinal microbiota and mycobiome in autism Gut-brain axis and ADHD in adolescents

    Respiratory diseases

    Respiratory microbiota and pulmonary infections associated with cystic fibrosis Nasal microbiota: a reliable marker of bronchiolitis severity

    Gastrointestinal disorders

    Infectious diarrhea and intestinal microbiota Is intestinal dysbiosis the cause of persistent diarrhea?

    Expert opinion

    Pr. Olivier Goulet : Gastrointestinal disorders in children, the need to act
    Pediatrics
    15.06.2021

    Autism: link between severity of the disorder and changes in the gut microbiota?

    Read the article
    21.01.2020

    A new generation of antibacterial agents? A plasmid capable of killing pathogenic bacteria

    Read the article
    Actu PRO : Le microbiote, rempart contre le rotavirus
    28.01.2020

    The microbiota as a barrier against rotavirus

    Read the article
    25.11.2021

    Scientific publications: Dr Science and Mr Fraud

    Read the article
    14.03.2022

    Does the nasal microbiota modulate the risk of otitis?

    Read the article
    11.03.2022

    When an infant’s sleep hinges on a few bacteria

    Read the article
    04.03.2022

    Antibiotics and cesarean delivery: how do they affect the newborn microbiota?

    Read the article
    Actu PRO : Malnutrition : agir sur le microbiote pour améliorer la croissance, un prototype à l’essai
    08.07.2021

    Malnutrition: acting on the microbiota in order to improve growth, a trial prototype

    Read the article
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    NL13_cover
    Check out latest newsletter
    IBS, Microbiota & Covid-19
    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Russian

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive once a month the “Microbiota Digest” to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    Photo: Postménopause : l'action bénéfique de l'estradiol sur le microbiote vaginal
    22.06.2022

    Postmenopause: the beneficial action of estradiol on the vaginal microbiota

    Read the article
    WMD_Foundation KOL USA 2018
    17.06.2022

    Dr. Yang (USA winner 2018): Gut microbiota & gut brain axis

    Read the article
    WMD_Foundation KOL USA 2017
    17.06.2022

    Dr. Singh (USA winner 2017): Microbiota & polyphenols

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive once a month the “Microbiota Digest” to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo